Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Fig. 2

Diagnostic performance of cerebrospinal fluid biomarkers. a Heat map of AUCs of the single biomarkers for all diagnostic comparisons. b ROC analysis of the logistic regression results for differential diagnosis of neurodegenerative disorders. Aβ 1–42 Amyloid-β peptide 1–42, AD Alzheimer’s disease, DLB Dementia with Lewy bodies, FABP3 Fatty acid binding protein 3, heart type, OND Other neurological diseases, PD Parkinson’s disease, PDD Parkinson’s disease with dementia, p-tau Phosphorylated tau 181, α-syn α-Synuclein, t-tau Total tau

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193